PTEN deletion is frequently found in solid tumors and hematologic malignancies, including prostate cancer, diffuse large B-cell lymphoma, glioma, endometrial carcinoma, hepatopancreatic ductal malignancy, and invasive bladder cancer [65–71]. The gene discussed is PTEN; the disease is cancer.